LIN

Linde is a high-quality industrial gases franchise with durable advantages from scale, onsite pipeline networks, and long-term take-or-pay contracts that make cash flows more resilient than most cyclicals. Its growth is increasingly tied to secular drivers like clean hydrogen, electronics, and healthcare, while recent capacity additions (e.g., a new air separation plant in North Carolina) reinforce customer stickiness and regional density. The main debate is not moat, but how much near-term industrial softness can offset those secular tailwinds.

Financially, 2025 results were strong: sales were $34.0B (+3% YoY), adjusted operating profit $10.1B (+4%), and adjusted EPS $16.46 (+6%). Net debt was about $21.9B at year-end 2025 (cash about $5.1B), which looks manageable given earnings power and contract visibility, but it does add sensitivity if rates or volumes worsen. Valuation is not cheap: at about $499/share, LIN trades near ~33x trailing EPS, implying investors are paying for stability and mid-to-high single-digit EPS compounding.

My 12-month thesis is that LIN remains a “compounder,” but returns will depend more on earnings delivery than multiple expansion at this valuation. Key catalysts are May 1, 2026 Q1 results (company guided Q1 adjusted EPS $4.20–$4.30) and progress converting its ~$10B project backlog into revenue. Key risks are a deeper industrial slowdown, project delays/cost inflation, and FX sensitivity (management has recently cited currency as a tailwind).

Recommendation: HOLD. The business quality and 2026 EPS trajectory are attractive, but the current premium multiple and net-debt load leave less margin for error if global industrial demand weakens.